Mettler-Toledo International (NYSE:MTD) Updates FY 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTDGet Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 46.050-46.700 for the period, compared to the consensus EPS estimate of 45.780. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q1 2026 guidance to 8.600-8.750 EPS.

Analyst Ratings Changes

Several brokerages recently issued reports on MTD. Wells Fargo & Company boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Barclays reduced their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research note on Monday, December 15th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research report on Monday, December 15th. Finally, Morgan Stanley began coverage on Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price target for the company. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,441.67.

View Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,375.92 on Friday. The stock has a fifty day simple moving average of $1,421.95 and a two-hundred day simple moving average of $1,358.73. The firm has a market capitalization of $28.11 billion, a PE ratio of 32.67, a PEG ratio of 4.11 and a beta of 1.42. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating the consensus estimate of $12.76 by $0.60. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a negative return on equity of 384.02% and a net margin of 21.59%.The business’s revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the business earned $12.41 earnings per share. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, sell-side analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 236 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider directly owned 159 shares in the company, valued at $225,554.22. This represents a 59.75% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 1,895 shares of the company’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,696,789.76. This represents a 26.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 19,565 shares of company stock worth $28,683,737 in the last quarter. 1.94% of the stock is owned by insiders.

Key Headlines Impacting Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

Institutional Investors Weigh In On Mettler-Toledo International

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. raised its holdings in Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 30 shares during the period. Baird Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after buying an additional 40 shares during the period. Jump Financial LLC lifted its stake in Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after acquiring an additional 125 shares during the period. Cerity Partners LLC raised its holdings in shares of Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after purchasing an additional 392 shares in the last quarter. Finally, AXA S.A. raised its stake in Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after buying an additional 131 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Further Reading

Earnings History and Estimates for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.